Trang 1 từ 2363 các kết quả
BACKGROUND
Opioid-induced constipation (OIC) is common among children and adolescents and young adults (AYA) with progressive incurable cancer. Although methylnaltrexone is a successful treatment for OIC in adult cancer patients, no case series has established its safety and efficacy in pediatric
Background: Constipation is frequently encountered in patients undergoing brain tumor resection. Constipation has negative effects on daily living, well-being, and individuals' quality of life. We examined the impact of acupuncture and
OBJECTIVE
To assess the effect of auricular points treatment combined with acupoints application on patient with constipation after lung cancer surgery.
METHODS
Design and participants: This is a single-center randomized controlled trial. Totally 341 after lung cancer surgery patients were randomly
BACKGROUND
Constipation affects many patients receiving long-term opioid therapy for cancer pain. Little is known about the nature of psychological distress and the burden associated with this problem. This information may inform the development of effective treatment strategies and ameliorate
Constipation is a frequent, distressing, and underestimated complication in patients with advanced cancer. It may develop from general disturbances that may or may not be cancer related, but the use of opioids is one of the main causes in this population. Opioids affect the intestine by reducing
Opioid-induced constipation (OIC) is the most common side effect in patient-prescribed opioids for cancer pain treatment. Current guidelines recommend routine prescription of a laxative for preventing OIC in all patients prescribed an opioid unless a contraindication exists. We Constipation is a major source of distress for patients with cancer, significantly affecting quality of life. It can be secondary to disease sequelae, side effects of treatment, or preexisting conditions. It often is unrecognized, underassessed, and ineffectively managed. Nurses play a key role in
BACKGROUND
Constipation is a common problem for advanced cancer patients, and is generally inadequately treated.
OBJECTIVE
The aim of this study was to prospectively evaluate the effectiveness and tolerability of amidotrizoate (AM) in patients unresponsive to current laxatives.
METHODS
A consecutive
OBJECTIVE
The purpose of this trial was to evaluate the effect of long-term treatment with either oral sustained-release hydromorphone (HM) or morphine (M) on nausea, emesis, and constipation.
METHODS
In a prospective, open-labeled, controlled trial, 100 outpatients with cancer pain and treatment
Constipation is a common problem in children and young people with cancer. Treatment of this complication is subject to wide variation in practice. We undertook a systematic review of randomized controlled trials to build a rational approach to prophylaxis and treatment of this complication.
Cancer-related constipation is common and a significant detractor from patient quality of life. It has many possible causes and is still not well understood. Information is lacking on therapies for cancer-related constipation among current medications approved by the US Food and Drug Administration
Constipation is highly prevalent in patients with cancer and is a source of tremendous suffering. The physiology of the gastrointestinal tract and the pathophysiology of constipation are being elucidated. Therapeutic agents include stool softeners, osmotic agents, stimulant laxatives, lubricants,
Opioid-induced constipation (OIC) is a distressing physical symptom for patients with cancer taking opioids. Total opioid consumption may contribute to developing worsening OIC-related symptoms. We completed a retrospective analysis examining the association of total daily opioid BACKGROUND
Physical activity has been found to play a role in cancer prevention. The purpose of this matched case-control study was to investigate the association between physical activity levels, water intake, constipation and colorectal cancer (CRC).
METHODS
Two hundred and thirty-two patients
Constipation is a common and debilitating symptom in patients with advanced cancer. If ignored, constipation will get worse. If left untreated, it can greatly reduce a patient's quality of life. An improved understanding of bowel function and knowledge of the recognised risk factors will lead to a